Phase I study of high-dose thiotepa with
β
Pession, Andrea; Prete, Arcangelo; Locatelli, Franco; Bella, Santiago; Melchiond
π
Article
π
1999
π
John Wiley and Sons
π
English
β 70 KB
π 2 views
Background. The aim of this phase I study was to define the maximum tolerated dose (MTD) of thiotepa (TT), administered with busulfan (BU) 480 mg/m 2 and etoposide 2,400 mg/m 2 , followed by autologous bone marrow transplantation (ABMT) or peripheral blood stem cell transplantation (APBSCT) support